Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | MITF | O75030 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 2/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | MGMT | P16455 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11903738 | 0.91 | DPP4 (0.38) | KDM4EALDH1A1MAPTHTTMITF | |
| SCHEMBL11903953 | 0.91 | DPP4 (0.38) | KDM4EALDH1A1MAPTHTTMITF | |
| Ethyl Acetate SCHEMBL27690065 | 0.85 | ALDH1A1 (0.45) | KDM4EALDH1A1MAPTHTTRAB9A | |
| SCHEMBL2495572 | 0.76 | KDM4E (0.50) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL18454300 | 0.75 | LMNA (0.37) | KDM4EALDH1A1MAPTHTTMITF | |
| SCHEMBL17555766 | 0.75 | MAPT (0.37) | KDM4EALDH1A1MAPTHTTMITF | |
| SCHEMBL1840937 | 0.75 | MEN1 (0.48) | KDM4EALDH1A1MAPTHTTMITF | |
| SCHEMBL17555611 | 0.75 | MAPT (0.44) | KDM4EMAPTHTTMITFNOD2 | |
| SCHEMBL17555750 | 0.73 | HTT (0.48) | KDM4EMAPTHTTMITFNPC1 | |
| SCHEMBL27350637 | 0.72 | MAPT (0.35) | KDM4EALDH1A1MAPTHTTMITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116924-A1 | METHOD FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE | TAGCYX BIOTECHNOLOGIES INC. (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4286395-A1 | METHOD FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE | TAGCyx Biotechnologies Inc. (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-116745308-A | Process for producing imidazopyridine derivative | 塔古西库斯生物株式会社 | 2023-09-12 | — | — | CN | disclosed |
| WO-2022163764-A1 | METHOD FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE | タグシクス・バイオ株式会社 | 2022-08-04 | — | — | WO | disclosed |
| EP-1847546-B1 | IMIDAZOPYRIDINE DERIVATIVE | RIKEN (JP) | 2012-11-28 | — | — | EP | disclosed |
| EP-1847546-B1 | IMIDAZOPYRIDINE DERIVATIVE | RIKEN (JP) | 2012-11-28 | — | — | EP | disclosed |
| EP-1970445-B1 | METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS | RIKEN (JP) | 2012-09-26 | — | — | EP | disclosed |
| CN-101365791-B | Method for replication of nucleic acid and novel artificial base pair | RIKEN | 2012-07-25 | — | — | CN | disclosed |
| US-8030478-B2 | Method for nucleic acid replication and novel artificial base pairs | RIKEN (JP) | 2011-10-04 | — | — | US | disclosed |
| CN-101107261-B | Imidazopyridine derivatives | RIKEN | 2011-02-09 | — | — | CN | disclosed |
| US-7615628-B2 | Imidazopyridine derivatives | RIKEN (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7615628-B2 | Imidazopyridine derivatives | RIKEN (JP) | 2009-11-10 | — | — | US | disclosed |
| CN-101365791-A | Method for replication of nucleic acid and novel artificial base pair | RIKEN (JP) | 2009-02-11 | — | — | CN | disclosed |
| EP-1970445-A1 | METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS | Riken (JP) | 2008-09-17 | — | — | EP | disclosed |
| US-20080125381-A1 | Imidazopyridine Derivatives | RIKEN (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20080125381-A1 | Imidazopyridine Derivatives | RIKEN (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20080125381-A1 | Imidazopyridine Derivatives | RIKEN (JP) | 2008-05-29 | — | — | US | disclosed |
| CN-101107261-A | imidazopyridine derivatives | RIKEN (JP) | 2008-01-16 | — | — | CN | disclosed |
| EP-1847546-A1 | IMIDAZOPYRIDINE DERIVATIVE | Riken (JP) | 2007-10-24 | — | — | EP | disclosed |
| EP-1847546-A1 | IMIDAZOPYRIDINE DERIVATIVE | Riken (JP) | 2007-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116924-A1 | METHOD FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE | XDH, TH, ABL1 | KDM4E 381/4885ALDH1A1 1167/4885MAPT 3161/4885 |
| US-20080125381-A1 | Imidazopyridine Derivatives | MKI67, IPO5, IMPA1 | KDM4E 552/4885ALDH1A1 591/4885MAPT 4483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.